全文获取类型
收费全文 | 39654篇 |
免费 | 2403篇 |
国内免费 | 208篇 |
专业分类
耳鼻咽喉 | 446篇 |
儿科学 | 1267篇 |
妇产科学 | 1044篇 |
基础医学 | 3952篇 |
口腔科学 | 1239篇 |
临床医学 | 3451篇 |
内科学 | 8609篇 |
皮肤病学 | 767篇 |
神经病学 | 2482篇 |
特种医学 | 1373篇 |
外国民族医学 | 5篇 |
外科学 | 7291篇 |
综合类 | 915篇 |
现状与发展 | 3篇 |
一般理论 | 30篇 |
预防医学 | 2685篇 |
眼科学 | 1424篇 |
药学 | 2966篇 |
1篇 | |
中国医学 | 279篇 |
肿瘤学 | 2036篇 |
出版年
2024年 | 43篇 |
2023年 | 435篇 |
2022年 | 1091篇 |
2021年 | 1729篇 |
2020年 | 1026篇 |
2019年 | 1329篇 |
2018年 | 1656篇 |
2017年 | 1204篇 |
2016年 | 1300篇 |
2015年 | 1394篇 |
2014年 | 1773篇 |
2013年 | 2167篇 |
2012年 | 3293篇 |
2011年 | 3169篇 |
2010年 | 1772篇 |
2009年 | 1568篇 |
2008年 | 2357篇 |
2007年 | 2449篇 |
2006年 | 2145篇 |
2005年 | 1909篇 |
2004年 | 1733篇 |
2003年 | 1435篇 |
2002年 | 1254篇 |
2001年 | 438篇 |
2000年 | 383篇 |
1999年 | 347篇 |
1998年 | 224篇 |
1997年 | 168篇 |
1996年 | 164篇 |
1995年 | 125篇 |
1994年 | 124篇 |
1993年 | 100篇 |
1992年 | 188篇 |
1991年 | 185篇 |
1990年 | 169篇 |
1989年 | 159篇 |
1988年 | 133篇 |
1987年 | 115篇 |
1986年 | 107篇 |
1985年 | 132篇 |
1984年 | 93篇 |
1983年 | 59篇 |
1982年 | 60篇 |
1981年 | 63篇 |
1980年 | 49篇 |
1979年 | 60篇 |
1978年 | 43篇 |
1977年 | 42篇 |
1976年 | 41篇 |
1973年 | 41篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
91.
Ghazal Arabidarrehdor Ali Tivay Ramin Bighamian Chris Meador George C. Kramer Jin-Oh Hahn Jose Salinas 《Burns : journal of the International Society for Burn Injuries》2021,47(2):371-386
This paper presents a mathematical model of blood volume kinetics and renal function in response to burn injury and resuscitation, which is applicable to the development and non-clinical testing of burn resuscitation protocols and algorithms. Prior mathematical models of burn injury and resuscitation are not ideally suited to such applications due to their limited credibility in predicting blood volume and urinary output observed in wide-ranging burn patients as well as in incorporating contemporary knowledge of burn pathophysiology. Our mathematical model consists of an established multi-compartmental model of blood volume kinetics, a hybrid mechanistic-phenomenological model of renal function, and novel lumped-parameter models of burn-induced perturbations in volume kinetics and renal function equipped with contemporary knowledge on burn-related physiology and pathophysiology. Using the dataset collected from 16 sheep, we showed that our mathematical model can be characterized with physiologically plausible parameter values to accurately predict blood volume kinetic and renal function responses to burn injury and resuscitation on an individual basis against a wide range of pathophysiological variability. Pending validation in humans, our mathematical model may serve as an effective basis for in-depth understanding of complex burn-induced volume kinetic and renal function responses as well as development and non-clinical testing of burn resuscitation protocols and algorithms. 相似文献
92.
L. Elliott K. Coulman N. S. Blencowe M. I. Qureshi K. S. Lee R. J. Hinchliffe R. Mouton 《Anaesthesia》2021,76(6):832-836
Interventions from randomised controlled trials can only be replicated if they are reported in sufficient detail. The results of trials can only be confidently interpreted if the delivery of the intervention was systematic and the protocol adhered to. We systematically reviewed trials of anaesthetic interventions published in 12 journals from January 2016 to September 2019. We assessed the detail with which interventions were reported, using the Consolidated Standards of Reporting Trials statement for non-pharmacological treatments. We analysed 162 interventions reported by 78 trials in 18,675 participants. Detail sufficiently precise to replicate the intervention was reported for 111 (69%) interventions. Intervention standardisation was reported for 135 (83%) out of the 162 interventions, and protocol adherence was reported for 20 (12%) interventions. Sixty (77%) out of the 78 trials reported the administrative context in which interventions were delivered and 36 (46%) trials detailed the expertise of the practitioners. We conclude that bespoke reporting tools should be developed for anaesthetic interventions and interventions in other areas such as critical care. 相似文献
93.
94.
Khalid Ibrahim Bzeizi Richard Smith Ali Albenmousa Madhukar Dama Faisal Aba-Alkhail Rajiv Jalan Dieter Broering 《Transplantation proceedings》2021,53(1):148-158
BackgroundRisk of nephrotoxicity in liver transplant patients on calcineurin inhibitors (CnIs) is a concern. Several controlled trials reported benefit of everolimus (EVR) in minimizing this risk when combined with a reduced CnI dose.BackgroundTo systematically review the efficacy and safety of EVR, alone or with reduced CnI dose, as compared to CnI alone post-liver transplantation.MethodsWe searched MEDLINE, Scopus, and the Cochrane Library for randomized controlled trials comparing EVR- and CnI-based regimens post-liver transplantation. Assessment of studies and data extraction were undertaken independently.ResultsEight studies were selected, describing 769 patients. Cockcroft-Gault GFR was higher at one (P = .05), 3, and 5 years (P = .030) in patients on EVR compared to those receiving CnI therapy. The composite endpoint of efficacy failure was similar between the 2 arms after 1, 3, and 5 years of study. More patients discontinued EVR due to adverse effects in 1 year; however, no difference was noted after 3 or 5 years. A higher rates of proteinuria, peripheral edema, and incisional hernia occurred in patients on EVR.ConclusionsThe analysis confirms noninferiority of EVR and reduced CnI combination. Combination regimen resulted in better renal function compared to standard CnI therapy. 相似文献
95.
96.
97.
98.
James F. Markmann Michael R. Rickels Thomas L. Eggerman Nancy D. Bridges David E. Lafontant Julie Qidwai Eric Foster William R. Clarke Malek Kamoun Rodolfo Alejandro Melena D. Bellin Kathryn Chaloner Christine W. Czarniecki Julia S. Goldstein Bernhard J. Hering Lawrence G. Hunsicker Dixon B. Kaufman Olle Korsgren Christian P. Larsen Xunrong Luo Ali Naji José Oberholzer Andrew M. Posselt Camillo Ricordi Peter A. Senior A. M. James Shapiro Peter G. Stock Nicole A. Turgeon 《American journal of transplantation》2021,21(4):1477-1492
99.
Ali Yildiz Ekrem Islamoglu Mustafa Yuksel Ibrahim Erol Kaan Karamik Tuncay Cakir Mutlu Ates Murat Savas 《Current Urology》2021,15(2):111
Background:To evaluate the changes in penile sensation by electrophysiological tests in patients who underwent radical prostatectomy (RP) and to demonstrate the role of dorsal penile nerve injury in postoperative erectile dysfunction.Materials and methods:Twenty-six volunteer patients who were eligible for RP were included in the study. Preoperative penile sensory electromyography and the International Index of Erectile Function-5 (IIEF-5) questionnaire were done for each patient. Erectile function assessment and electrophysiological evaluation of penile sensation were repeated at postoperative 3rd and 6th months.Results:Postoperative IIEF-5 scores and electromyography values were significantly lower than preoperative findings (p < 0.05). The IIEF-5 scores in the nerve sparing-RP (NS-RP) group were significantly higher than the non-nerve sparing-RP (NNS-RP) group in the postoperative period. Nerve conduction velocity values in the NS-RP group were also higher than the NNS-RP group at the postoperative 3rd and 6th months. However, these changes were not statistically significant (p > 0.05).Conclusions:Patients who underwent RP have decreased penile sensation due to cavernous nerve damage and a possible dorsal penile nerve injury. The decrease of penile sensation may be associated with postoperative erectile dysfunction. 相似文献
100.
S. Samaras S. Ashfield S.F. Ali L.J. Fopp J.R. Benson C.M. Malata 《Journal of plastic, reconstructive & aesthetic surgery》2021,74(5):957-965
IntroductionHormonal therapy with tamoxifen and aromatase inhibitors reduces breast cancer recurrence and mortality but represents a risk factor for thromboembolic events. Therefore, most surgeons discontinue hormonal agents before microvascular surgery and for a variable period thereafter. There are no guidelines regarding when therapy should be stopped (preoperatively) or when it should be resumed (post-operatively). We, therefore, audited our hospital practice with the objective of making recommendations for microvascular breast reconstruction patients.Patients and methodsA review was performed of all free flap breast reconstructions between 2014 and 2019. Patients were classified according to hormone medication status at operation. Timings of drug cessation and recommencement were recorded. Thrombotic events, namely flap microvascular thrombosis, deep vein thrombosis, superficial vein thrombosis and pulmonary embolism, were compared.ResultsA total of 240 patients had 275 free flaps over five years with 36 receiving hormone therapy within one month prior to surgery, which was discontinued 8.5 days (range: 0–28 days) before surgery. Intraoperative microvascular thromboses (HT 2.0%, NHT 0%, and p = 0.869) and post-operative microvascular complications/flap re-explorations (HT 6.6%, NHT 0%, and p = 0.234) were comparable between the two groups. Systemic venous thromboembolic events were also similar (HT 8.3%, NHT 6.1%, and p = 0.893). Age, BMI, smoking status and preoperative chemotherapy did not influence the incidence of thrombotic complications.ConclusionHormone therapy did not significantly increase the risk of thromboembolic events. Despite the widespread practice of withholding it for 2 weeks prior to reconstructive surgery, this study does not support such practice being beneficial in terms of thromboembolic events and flap viability. Large-scale trials are needed to establish definitive protocols. 相似文献